It’s a matter of public record that if HHS Secretary Robert F. Kennedy had his way, he’d ban direct-to-consumer pharma ...
Accurate labelling is equally important in blood transfusion services. Effectively tracking blood as it moves from donation ...
In this post-BIO virtual interview, editor-in-chief Jonah Comstock speaks with Iya Khalil, VP and head of data, AI, and ...
Metsera went public earlier this year, raising $275 million for its obesity pipeline against a backdrop of a fairly ...
The first patient has already been treated with bemdaneprocel, a one-shot treatment designed to replace the ...
Stealth BioTherapeutics has claimed FDA approval for Forzinity, the first treatment for ultra-rare disease Barth syndrome, ...
The FDA has cleared the new version for across most of the solid tumour indications already granted for Keytruda, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback